Dr. Hunter earned her Ph.D. in Psychology from UCLA with an emphasis in Learning and Behavior in 2001. Following her graduate work in behavioral neuroscience she completed three years of postdoctoral training in clinical research at the David Geffen School of Medicine at UCLA, before joining the faculty. Dr. Hunter is currently an Assistant Professor of Psychiatry and Assistant Director of the Laboratory of Brain, Behavior, and Pharmacology where she examines quantitative electroencephalography (qEEG) biomarkers to elicudate the contributions of pharmacodynamic and non-pharmacodynamic factors in achieving response to treatment for Major Depressive Disorder. Recently, she has begun a new line of research using qEEG biomarkers to investigate the neurobiological bases of cognitive difficulties reported by women who have received adjuvant treatment for breast cancer. One of the goals in developing such a biomarker is to help develop or identify effective treatments for breast cancer survivors who suffer from these cognitive problems in daily living.